1541 — ImmuneOnco Biopharmaceuticals (Shanghai) Share News
0.000.00%
Last trade - 00:00- HK$1.25bn
- HK$558.05m
- CNY154.29m
Brief: Immuneonco Biopharmaceuticals Shanghai Gets Orphan-Drug Designation From FDA
Brief: Immuneonco Biopharmaceuticals Shanghai Says Approval For Phase II Clinical Trial Of IMM2510
Brief: Immuneonco Biopharmaceuticals Shanghai Says Obtained Investigational New Drug Approval
Brief: Immuneonco Biopharmaceuticals Shanghai Announces Subscription Of Wealth Management Product